BRD9 Antibody Polyclonal

• Description:

  BRD9 Antibody Polyclonal_x000D_ Catalog number: B2016920_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 10 µL_x000D_ Molecular Weight or Concentration: 85 kDa_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20¬∞C_x000D_ Keywords: PRO9856, LAVS3040_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Hsu PC, Kadlubar SA, Siegel ER, Rogers LJ, Todorova VK, Su LJ, Makhoul I. Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer PLoS One. 2020 Apr 16;15(4):e0230248._x000D_ 2: Xiao M, Kondo S, Nomura M, Kato S, Nishimura K, Zang W, Zhang Y, Akashi T, Viny A, Shigehiro T, Ikawa T, Yamazaki H, Fukumoto M, Tanaka A, Hayashi Y, Koike Y, Aoyama Y, Ito H, Nishikawa H, Kitamura T, Kanai A, Yokoyama A, Fujiwara T, Goyama S, Noguchi H, Lee SC, Toyoda A, Hinohara K, Abdel-Wahab O, Inoue D. BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state Nat Commun. 2023 Dec 15;14(1):8372._x000D_ 3: Deng Z, Zhang Y, Zhu Y, Zhu J, Li S, Huang Z, Qin T, Wu J, Zhang C, Chen W, Huang D, Ye W. BRD9 Inhibition Attenuates Matrix Degradation and Pyroptosis in Nucleus Pulposus by Modulating the NOX1/ROS/NF-Œ∫B axis Inflammation. 2023 Jun;46(3):1002-1021._x000D_ 4: Mair NK, Hale BG. Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon Sci Rep. 2022 Sep 13;12(1):15360._x000D_ 5: Ali MM, Naz S, Ashraf S, Knapp S, Ul-Haq Z. Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition Int J Biol Macromol. 2023 Mar 1;230:123428._x000D_ 6: Colarusso E, Chini MG, Bifulco G, Lauro G, Giordano A. Identification and Development of BRD9 Chemical Probes Pharmaceuticals (Basel). 2024 Mar 19;17(3):392._x000D_ 7: Ali MM, Ashraf S, Nure-E-Alam M, Qureshi U, Khan KM, Ul-Haq Z. Identification of Selective BRD9 Inhibitor via Integrated Computational Approach Int J Mol Sci. 2022 Nov 4;23(21):13513._x000D_ 8: Zhu Q, Gu X, Wei W, Wu Z, Gong F, Dong X. BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma Cancer Med. 2023 Jan;12(2):1572-1587._x000D_ 9: Mu J, Sun X, Zhao Z, Sun H, Sun P. BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors Cell Death Dis. 2021 Oct 19;12(11):962._x000D_ 10: Wang X, Wang S, Troisi EC, Howard TP, Haswell JR, Wolf BK, Hawk WH, Ramos P, Oberlick EM, Tzvetkov EP, Ross A, Vazquez F, Hahn WC, Park PJ, Roberts CWM. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors Nat Commun. 2019 Apr 23;10(1):1881. _x000D_ _x000D_ Products Related to BRD9 Antibody Polyclonal can be found at Antibodies

• Short Description:

  Catalog Number: B2016920 (10 µL)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5

• CAS Number:

  9007-83-4